DE60221009T2 - Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind - Google Patents

Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind Download PDF

Info

Publication number
DE60221009T2
DE60221009T2 DE60221009T DE60221009T DE60221009T2 DE 60221009 T2 DE60221009 T2 DE 60221009T2 DE 60221009 T DE60221009 T DE 60221009T DE 60221009 T DE60221009 T DE 60221009T DE 60221009 T2 DE60221009 T2 DE 60221009T2
Authority
DE
Germany
Prior art keywords
biodegradable
copolymer
biologically compatible
moiety
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221009T
Other languages
German (de)
English (en)
Other versions
DE60221009D1 (de
Inventor
Meidong Lang
Chih-Chang Ithaca CHU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of DE60221009D1 publication Critical patent/DE60221009D1/de
Publication of DE60221009T2 publication Critical patent/DE60221009T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
DE60221009T 2001-05-07 2002-03-20 Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind Expired - Lifetime DE60221009T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28880601P 2001-05-07 2001-05-07
US288806P 2001-05-07
PCT/US2002/006642 WO2002090417A1 (en) 2001-05-07 2002-03-20 Biodegradable copolymers linked to segment with a plurality of functional groups

Publications (2)

Publication Number Publication Date
DE60221009D1 DE60221009D1 (de) 2007-08-16
DE60221009T2 true DE60221009T2 (de) 2008-03-13

Family

ID=23108719

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60221009T Expired - Lifetime DE60221009T2 (de) 2001-05-07 2002-03-20 Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind
DE0001392751T Pending DE02717541T1 (de) 2001-05-07 2002-03-20 Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0001392751T Pending DE02717541T1 (de) 2001-05-07 2002-03-20 Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind

Country Status (9)

Country Link
US (1) US6830747B2 (cg-RX-API-DMAC7.html)
EP (1) EP1392751B1 (cg-RX-API-DMAC7.html)
JP (1) JP4391750B2 (cg-RX-API-DMAC7.html)
AT (1) ATE366270T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002248535B2 (cg-RX-API-DMAC7.html)
CA (1) CA2440394C (cg-RX-API-DMAC7.html)
DE (2) DE60221009T2 (cg-RX-API-DMAC7.html)
ES (1) ES2220247T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002090417A1 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
EP1334990A1 (en) * 2002-02-06 2003-08-13 Polyganics B.V. DL-Lactide-epsilon-caprolactone copolymers
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
WO2004075781A2 (en) * 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
CN1878545A (zh) 2003-09-15 2006-12-13 奥德威研究院 甲状腺激素类似物及其使用方法
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US20060188486A1 (en) * 2003-10-14 2006-08-24 Medivas, Llc Wound care polymer compositions and methods for use thereof
AU2005244848A1 (en) * 2004-05-12 2005-12-01 Medivas, Llc Wound healing polymer compositions and methods for use thereof
US8603634B2 (en) 2004-10-27 2013-12-10 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US20060089485A1 (en) * 2004-10-27 2006-04-27 Desnoyer Jessica R End-capped poly(ester amide) copolymers
US8007775B2 (en) 2004-12-30 2011-08-30 Advanced Cardiovascular Systems, Inc. Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
US8057543B2 (en) * 2005-01-28 2011-11-15 Greatbatch Ltd. Stent coating for eluting medication
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US20100209382A1 (en) 2005-09-16 2010-08-19 Ordway Research Institute, Inc. Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
EP1917971A1 (en) 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Substained release formulations comprising very low molecular weight polymers
EP2120913B1 (en) * 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US8974776B2 (en) * 2007-05-14 2015-03-10 Covidien Lp Biodegradable peptide releasing polymers
WO2010120506A1 (en) 2009-03-31 2010-10-21 Ordway Research Institute, Inc. Combination treatment of cancer with cetuximab and tetrac
WO2010148007A2 (en) 2009-06-17 2010-12-23 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
US8771323B2 (en) 2010-11-12 2014-07-08 Silver Bullet Therapeutics, Inc. Bone implant and systems that controllably releases silver
US9114197B1 (en) 2014-06-11 2015-08-25 Silver Bullett Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US9821094B2 (en) 2014-06-11 2017-11-21 Silver Bullet Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US8927004B1 (en) 2014-06-11 2015-01-06 Silver Bullet Therapeutics, Inc. Bioabsorbable substrates and systems that controllably release antimicrobial metal ions
EP2470257B1 (en) 2009-08-27 2015-03-04 Silver Bullet Therapeutics Inc. Bone implants for the treatment of infection
US10265435B2 (en) 2009-08-27 2019-04-23 Silver Bullet Therapeutics, Inc. Bone implant and systems and coatings for the controllable release of antimicrobial metal ions
US9314551B2 (en) * 2010-05-14 2016-04-19 Boston Scientific Scimed, Inc. Block copolymer-coated endoprosthesis
US20120189860A1 (en) * 2011-01-24 2012-07-26 Fina Technology, Inc. Polymeric compositions comprising polylactic acid oligomers and methods of making the same
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP2723801B1 (en) 2011-06-23 2017-01-18 DSM IP Assets B.V. New biodegradable polyesteramide copolymers for drug delivery
US10538864B2 (en) 2012-10-24 2020-01-21 Dsm Ip Assets, B.V. Fibers comprising polyesteramide copolymers for drug delivery
JP6016577B2 (ja) * 2012-10-24 2016-10-26 大阪瓦斯株式会社 ポリ乳酸含有ブロック共重合体グラフトポリロタキサン及び該ブロック共重合体グラフトポリロタキサンを含有する樹脂組成物
WO2015074050A1 (en) 2013-11-18 2015-05-21 Nanopharmaceuticals Llc Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
ES2782428T3 (es) 2014-04-18 2020-09-15 Univ Auburn Formulaciones vacunales de partículas para la inducción de inmunidad innata y adaptativa
US10293044B2 (en) 2014-04-18 2019-05-21 Auburn University Particulate formulations for improving feed conversion rate in a subject
US9452242B2 (en) 2014-06-11 2016-09-27 Silver Bullet Therapeutics, Inc. Enhancement of antimicrobial silver, silver coatings, or silver platings
CN107106509B (zh) 2014-12-18 2021-11-30 帝斯曼知识产权资产管理有限公司 用于递送酸敏感药物的药物递送系统
US10583199B2 (en) 2016-04-26 2020-03-10 Northwestern University Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
CA3026504A1 (en) 2016-06-07 2017-12-14 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with .alpha..nu..beta.3 integrin thyroid antagonists
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US12383246B2 (en) 2020-10-12 2025-08-12 Abbott Cardiovascular Systems, Inc. Vessel closure device with improved safety and tract hemostasis
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists
TWI867498B (zh) * 2023-04-17 2024-12-21 星歐光學股份有限公司 聚合物、塗佈材料及組裝產品

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132735A (en) * 1975-06-27 1979-01-02 Lever Brothers Company Detergent compositions
JPS56157422A (en) * 1980-05-07 1981-12-04 Mitsui Toatsu Chem Inc Acetylated polyglycolic acid and preparation thereof
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4789724A (en) * 1986-10-17 1988-12-06 Massachusetts Institute Of Technology Preparation of anhydride copolymers
US4999417A (en) * 1989-03-30 1991-03-12 Nova Pharmaceutical Corporation Biodegradable polymer compositions
FR2707653B1 (fr) * 1993-07-16 1995-09-15 Vetoquinol Sa Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.
JP3367577B2 (ja) * 1994-05-24 2003-01-14 東洋紡績株式会社 酸末端封鎖ポリ乳酸
JP3524195B2 (ja) * 1994-02-21 2004-05-10 武田薬品工業株式会社 徐放性製剤用基剤
JP3490171B2 (ja) * 1994-02-21 2004-01-26 武田薬品工業株式会社 生体内分解性ポリマーの末端カルボキシル基におけるエステル
US5629384A (en) * 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
US5516881A (en) * 1994-08-10 1996-05-14 Cornell Research Foundation, Inc. Aminoxyl-containing radical spin labeling in polymers and copolymers
EP0696605B1 (de) * 1994-08-10 2000-09-20 Peter Neuenschwander Biokompatibles Blockcopolymer
US5485496A (en) * 1994-09-22 1996-01-16 Cornell Research Foundation, Inc. Gamma irradiation sterilizing of biomaterial medical devices or products, with improved degradation and mechanical properties
US5610241A (en) * 1996-05-07 1997-03-11 Cornell Research Foundation, Inc. Reactive graft polymer with biodegradable polymer backbone and method for preparing reactive biodegradable polymers
EP1144013B1 (en) * 1998-11-02 2007-03-21 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Lactone bearing absorbable polymers
WO2000032238A1 (en) * 1998-12-03 2000-06-08 Scimed Life Systems, Inc. Stent having drug crystals thereon
WO2000048573A1 (de) * 1999-02-19 2000-08-24 Bioserv Ag Bioabbaubare komposite zur herstellung von mikrokapseln
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes

Also Published As

Publication number Publication date
EP1392751A4 (en) 2005-01-26
WO2002090417A1 (en) 2002-11-14
ES2220247T1 (es) 2004-12-16
EP1392751B1 (en) 2007-07-04
JP4391750B2 (ja) 2009-12-24
CA2440394C (en) 2011-10-04
US20030027940A1 (en) 2003-02-06
CA2440394A1 (en) 2002-11-14
DE02717541T1 (de) 2004-08-26
EP1392751A1 (en) 2004-03-03
US6830747B2 (en) 2004-12-14
AU2002248535B2 (en) 2006-06-08
JP2004526043A (ja) 2004-08-26
ATE366270T1 (de) 2007-07-15
DE60221009D1 (de) 2007-08-16
ES2220247T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
DE60221009T2 (de) Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind
EP0696605B1 (de) Biokompatibles Blockcopolymer
DE69818693T2 (de) Neue polymerzusammensetzungen
DE69613481T2 (de) Hydrogele auf basis von dreiblockcopolymerisate, ihre herstellung und ihre verwendung
DE3751964T2 (de) Herstellung und Verwendung von hochmolekularen Polyanhydriden
DE69617277T2 (de) Absorbierbare Polyalkylendiglycolate
DE69730889T2 (de) Resorbierbare Copolymere und Mischungen von 6,6-Dialkyl-1,4-dioxepan-2-on und seinem cyclischen Dimeren
DE69734905T2 (de) Absorbierbare Polyoxaamide enthaltende Mischungen
DE69736186T2 (de) Verfahren und zusammensetzungen zur verminderung oder vermeidung der postoperativen adhäsionsbildung
DE69629408T2 (de) Absorbierbare Polyoxaester
AU2002248535A1 (en) Biodegradable copolymers linked to segment with a plurality of functional groups
DE69826882T2 (de) Bioresorbierbare zusammensetzungen für implantierfähige prothesen
DE60026065T2 (de) Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten
JP4335002B2 (ja) 生分解性多価アルコールエステル
DE69735067T2 (de) Verfahren zur herstellung von polymerüberzügen aus polyethylenoxidketten mit kovalent gebundenen bioaktiven substanzen
DE112011103342T5 (de) Stickstoffoxid-Abgabesysteme unter Verwendung von wärmeempfindlichen svnthetischen Polymeren
DE4224401A1 (de) Neue biologisch abbaubare Polymere für die Arzneistoffgalenik
EP1498147B1 (de) Abbaubares biokompatibles Blockcopolymer
DE2723911A1 (de) Unter normalbedingungen festes bioresorbierbares hydrolysierbares polymeres reaktionsprodukt
CH671402A5 (cg-RX-API-DMAC7.html)
EP2490728A1 (de) Bioabbaubares hydrogel
DE60220796T2 (de) Positiv geladenes amphiphiles blockcopolymer als arzneistoffträger und komplex davon mit negativ geladenem arzneistoff
DE69425669T2 (de) Verfahren zur Herstellung von hochmolekularen polyesterpolycarbonaten
DE112006000685B4 (de) Temperatur- und pH-empfindliches Blockcopolymer und daraus hergestellte Polymerhydrogele
DE69723818T2 (de) Polyesteranhydride und ihre zwischenprodukte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition